This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
After completion of my study on the safety of long-term tetracycline therapy for acne (Arch Dermatol 112:1603-1605, 1976), it seemed to me that physicians would appreciate some suggestions concerning blood testing for acne patients who are receiving long-term tetracycline therapy. The following sequence for testing is suggested, but this is not meant to be restrictive.First, take a good history from your patient. If the patient relates unusual medical problems, take appropriate tests including a complete blood cell count (CBC) and blood chemistry studies using an automated 12-factor analysis system. Next, if the patient has been receiving long-term antibiotic therapy for one year or longer, previous to your first visit, get a 12-factor blood chemistry analysis test and a CBC. Third, if you institute antibiotic therapy, give the patient an information sheet stating in a few words the mild nonserious side effects and the fact that there
Sauer GC. Suggested Sequence of Testing for Acne Patients Receiving Long-Term Tetracycline Therapy. Arch Dermatol. 1977;113(9):1303. doi:10.1001/archderm.1977.01640090151056
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: